Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-24 · accession 0001209191-23-013708 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-28 | 2023-02-27 | VRTX | Arbuckle Stuart A | EVP, COO | S - Sale | $287.47 | -5,034 | 57.8K | -8% | -$1.45M |
| 2023-02-28 | 2023-02-24 | VRTX | Arbuckle Stuart A | EVP, COO | F - Tax | $289.12 | -4,714 | 61.6K | -7% | -$1.36M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-27 | S | D | 800 | $288.92 | 56,556 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $288.92 (range $288.57 to $289.38). (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-02-27 | S | D | 400 | $287.59 | 57,356 | D | — | — | (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $287.59 (range $287.57 to $287.60). |
| 3 | Common | Common Stock | 2023-02-27 | S | D | 3,834 | $287.16 | 57,756 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $287.16 (range $286.57 to $287.51). (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2023-02-24 | F | D | 4,714 | $289.12 | 61,590 | D | — | — |